IMPAX Laboratories, Inc. (IPXL) to Present at the Deutsche Bank (DB) 38th Annual Health Care Conference
5/24/2013 7:36:56 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Board Steps in to Oversee Hayward Manufacturing Issues
5/21/2013 11:18:04 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) to Present at the UBS Global Healthcare Conference
5/20/2013 7:02:32 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.
5/17/2013 9:46:12 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) to Present at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/10/2013 7:48:17 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Reports First Quarter 2013 Results
5/2/2013 8:03:19 AM
More...
|
GlaxoSmithKline (GSK), IMPAX Laboratories, Inc. (IPXL) End Collaboration on IPX066 Parkinson's Treatment
4/29/2013 7:08:59 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Schedules Conference Call and Webcast for First Quarter 2013 Financial Results
4/3/2013 11:58:14 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Continues to Ignore FDA Warnings, Causing Delays
3/15/2013 7:03:03 AM
More...
|
FDA Finds Problems Continue at IMPAX Laboratories, Inc. (IPXL) Factory in Hayward
3/6/2013 8:13:30 AM
More...
|
|